PACESETTER: Program to Avoid Cerebrovascular Events Through Systematic Electronic Tracking and Tailoring of an Eminent Risk-factor
Key facts
- Who runs it
- Northern California Institute of Research and Education
- Where
- Charleston, Columbia, Orangeburg, and San Francisco, United StatesSee the 4 sites
- Trial code
- Status
- Terminated
- People taking part
- 120 people enrolled
- Started
- 14 Jul 2020
- Ended
- 28 Feb 2024
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- PACESETTER
- Record updated
- 11 December 2025
- Why it stopped
- Study delays and ran out of funding
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- African American or non-Hispanic white
- history of stroke (within six months of symptom onset)
- uncontrolled HTN (SBP ≥ 130 mmHg at the last clinical encounter post-stroke prior to recruitment)
- owning a smartphone with a data plan
- able to take their own BP and self-administer medications
Who cannot take part
- Any condition that would limit participation in follow up assessments including severe cognitive impairment/dementia; severe global disability (modified Rankin Score ≥ 3); BMI> 40kg/m\^2; Not being able to speak, hear, or understand English
Where in United States
- Medical University of South CarolinaCharleston, United States
- University of South CarolinaColumbia, United States
- Regional Medical Center: Orangeburg HospitalOrangeburg, United States
- NCIRESan Francisco, United States
About the trial
What the trial wants to find out
Program to Avoid Cerebrovascular Events through Systematic Electronic Tracking and Tailoring of an Eminent Risk-factor (PACESETTER) aims to assess the incorporation of its stroke intervention into 2 safety net/academic health systems in a given US state especially burdened by stroke, thereby enhancing knowledge about the complexity of stroke interventions, and especially the nature of the challenges encountered in low resource settings and for populations traditionally underrepresented in research. Altogether, the intervention, if proven implementable and effective, may eventually be exported to other medically underserved populations in the US beyond SC as a feasible model of post-stroke management.
The 2 groups in the trial
- PACESETTERTreatment being tested
Participants in the PACESETTER arm received a multicomponent, mHealth-enabled self-management program designed to improve post-stroke blood-pressure control. Each participant was provided a Bluetooth-enabled UA-767Plus BT home blood-pressure monitor, a Vaica electronic medication tray that emitted visual and auditory reminders, and the PACESETTER smartphone app. The app delivered instructional videos, enabled automatic transmission of BP and adherence data to a secure server, and generated tailored SMS messages based on self-determination-theory constructs of competence and autonomous regulation. Participants also received twice-weekly educational text messages regarding hypertension and stroke prevention, medication adherence, and communication with clinicians. Bi-weekly adherence and BP summaries were sent to study physicians to guide medication adjustments. Study coordinators contacted participants monthly to ensure device functioning and collect follow-up data.
- Healthy Lifestyle Intervention GroupNo study treatment, for comparison
General lifestyle SMS matched in frequency and length to the intervention; monthly follow-ups; no devices, adherence monitoring, or physician-directed feedback.
Results explained
A paper that names this trial, explained in plain words.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Program to Avoid Cerebrovascular Events Through Systematic Electronic Tracking and Tailoring of an Eminent Risk-factor
- Publications
- Program to Avoid Cerebrovascular Events Through Systematic Electronic Tracking and Tailoring of an Eminent Risk Factor: A Randomized Trial.Journal of the American Heart Association, 2026
- Program to Avoid Cerebrovascular Events through Systematic Electronic Tracking and Tailoring of an Eminent Risk factor: Protocol of a RCT.Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2021
- Record updated
- 11 December 2025